ZS Associates

Hi there,

What separates first-launch leaders from the rest? They don’t wait until launch to build the commercial capabilities they need to grow.

Our latest article explores six principles that help emerging biopharma organizations build a trusted, AI-ready commercial foundation before approval — setting the stage for a stronger launch today and scalable growth tomorrow.

See what leaders do differently

This is a sponsored email from ZS sent by Endpoints (2029 Becker Drive, Lawrence, KS 66047 USA) from an account we use for sending messages only.

Want to send your own email like this to Endpoints News subscribers? Please contact Melissa Nazzaro instead of replying to this email: melissa@endpointsnews.com.

No longer wish to receive certain emails from Endpoints? You may update your unsubscribe preferences or upgrade to an Insider subscription for the option to disable sponsored messages.

Unsubscribe entirely from all news and sponsored posts by clicking the link below: Unsubscribe